HRT Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-10,030
| Closed | -$4.04M | – | 3211 |
|
2024
Q4 | $4.04M | Sell |
10,030
-33,267
| -77% | -$13.4M | 0.02% | 387 |
|
2024
Q3 | $20.1M | Sell |
43,297
-80,212
| -65% | -$37.3M | 0.1% | 110 |
|
2024
Q2 | $57.9M | Buy |
+123,509
| New | +$57.9M | 0.32% | 38 |
|
2024
Q1 | – | Sell |
-7,948
| Closed | -$3.23M | – | 2981 |
|
2023
Q4 | $3.23M | Buy |
7,948
+5,406
| +213% | +$2.2M | 0.02% | 430 |
|
2023
Q3 | $883K | Sell |
2,542
-1,272
| -33% | -$442K | 0.01% | 961 |
|
2023
Q2 | $1.34M | Buy |
+3,814
| New | +$1.34M | 0.01% | 725 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 3589 |
|
2022
Q1 | – | Sell |
-63,603
| Closed | -$14M | – | 3620 |
|
2021
Q4 | $14M | Buy |
+63,603
| New | +$14M | 0.08% | 118 |
|
2021
Q3 | – | Sell |
-6,834
| Closed | -$1.38M | – | 3555 |
|
2021
Q2 | $1.38M | Sell |
6,834
-25,442
| -79% | -$5.13M | 0.01% | 783 |
|
2021
Q1 | $6.94M | Buy |
+32,276
| New | +$6.94M | 0.07% | 178 |
|
2019
Q4 | – | Sell |
-9,191
| Closed | -$1.56M | – | 1586 |
|
2019
Q3 | $1.56M | Buy |
+9,191
| New | +$1.56M | 0.07% | 179 |
|
2019
Q2 | – | Sell |
-7,768
| Closed | -$1.43M | – | 897 |
|
2019
Q1 | $1.43M | Buy |
+7,768
| New | +$1.43M | 0.22% | 56 |
|
2018
Q3 | – | Sell |
-5,368
| Closed | -$912K | – | 463 |
|
2018
Q2 | $912K | Buy |
5,368
+3,443
| +179% | +$585K | 0.33% | 41 |
|
2018
Q1 | $313K | Buy |
+1,925
| New | +$313K | 0.15% | 129 |
|
2015
Q4 | – | Sell |
-2,584
| Closed | -$269K | – | 119 |
|
2015
Q3 | $269K | Buy |
+2,584
| New | +$269K | 0.23% | 58 |
|